Journal for ImmunoTherapy of Cancer (Nov 2023)
1337 The preclinical characterization and translational research of ATG-031, a first-in-class humanized anti-CD24 antibody, for the treatment of solid tumors and hematological malignancies
Abstract
No abstracts available.